Coherus Oncology, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
Coherus Oncology, Inc. (CHRS) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$183.12 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-09
- Coherus Oncology, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$183.12M.
- Coherus Oncology, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$215.39M.
- Coherus Oncology, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$291.75M.
- Coherus Oncology, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2021 was -$287.06M, a 314.84% decline from fiscal 2020.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$183.12M 10-K · filed 2026-03-09 | |
| 2024-12-31 | -$215.39M 10-K · filed 2026-03-09 | $28.51M 10-K · filed 2025-03-17 |
| 2023-12-31 | -$222.14M 8-K · filed 2025-11-13 | -$238.27M 10-K · filed 2024-03-15 |
| 2022-12-31 | -$291.75M 10-K · filed 2025-03-17 | |
| 2021-12-31 | -$287.06M 10-K · filed 2024-03-15 | |
| 2020-12-31 | $133.62M 10-K · filed 2023-03-06 | |
| 2019-12-31 | $92.58M 10-K · filed 2022-02-23 | $92.58M 10-K · filed 2020-02-27 |
| 2018-12-31 | -$208.84M 10-K · filed 2021-02-25 | |
| 2017-12-31 | -$222.67M 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |